tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PEN Stock Latest News

Penumbra’s Promising Growth: Buy Rating Backed by Strong Portfolio and Technological Advancements
RatingsPenumbra’s Promising Growth: Buy Rating Backed by Strong Portfolio and Technological Advancements
12d ago
PEN
Penumbra’s Promising Growth: Buy Rating Backed by STORM-PE Trial and Market Expansion
PremiumRatings
Penumbra’s Promising Growth: Buy Rating Backed by STORM-PE Trial and Market Expansion
13d ago
PEN
Penumbra Inc. Reports Strong Q3 Growth Amid Challenges
PremiumCompany Announcements
Penumbra Inc. Reports Strong Q3 Growth Amid Challenges
26d ago
PEN
Penumbra price target raised to $286 from $285 at Evercore ISI
PremiumThe Fly
Penumbra price target raised to $286 from $285 at Evercore ISI
26d ago
PEN
Penumbra’s Hold Rating: Balancing Recent Success with Future Uncertainties
PremiumRatings
Penumbra’s Hold Rating: Balancing Recent Success with Future Uncertainties
27d ago
PEN
Penumbra price target raised to $355 from $350 at Canaccord
PremiumThe FlyPenumbra price target raised to $355 from $350 at Canaccord
27d ago
PEN
Penumbra price target raised to $275 from $265 at JPMorgan
Premium
The Fly
Penumbra price target raised to $275 from $265 at JPMorgan
27d ago
PEN
Penumbra’s Strong Financial Performance and Strategic Advancements Reinforce Buy Rating
Premium
Ratings
Penumbra’s Strong Financial Performance and Strategic Advancements Reinforce Buy Rating
27d ago
PEN
Buy Rating for Penumbra: Strong Q3 Performance and Future Growth Catalysts
PremiumRatings
Buy Rating for Penumbra: Strong Q3 Performance and Future Growth Catalysts
27d ago
PEN
Penumbra, Inc. Reports Strong Q3 2025 Growth
PremiumCompany Announcements
Penumbra, Inc. Reports Strong Q3 2025 Growth
27d ago
PEN
Closing Bell Movers: Qualcomm down 3%, Robinhood slips 2% on earnings
PremiumThe Fly
Closing Bell Movers: Qualcomm down 3%, Robinhood slips 2% on earnings
27d ago
LZ
ALL
Penumbra reports Q3 non-GAAP EPS 97c, consensus 92c
PremiumThe Fly
Penumbra reports Q3 non-GAAP EPS 97c, consensus 92c
27d ago
PEN
Penumbra raises FY25 revenue view to $1.375B-$1.380B from $1.355B-$1.370B
PremiumThe FlyPenumbra raises FY25 revenue view to $1.375B-$1.380B from $1.355B-$1.370B
27d ago
PEN
Buy Rating on Penumbra: Capitalizing on Positive STORM-PE Trial Results and Market Misunderstanding
Premium
Ratings
Buy Rating on Penumbra: Capitalizing on Positive STORM-PE Trial Results and Market Misunderstanding
29d ago
PEN
Penumbra Inc. (PEN) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Penumbra Inc. (PEN) Q3 Earnings Cheat Sheet
30d ago
PEN
William Blair healthcare analysts hold analyst/industry conference call
PremiumThe Fly
William Blair healthcare analysts hold analyst/industry conference call
1M ago
PEN
Penumbra Inc. Launches i-RISE Study to Enhance Stroke Treatment Insights
PremiumCompany Announcements
Penumbra Inc. Launches i-RISE Study to Enhance Stroke Treatment Insights
1M ago
PEN
Penumbra Inc.’s STRIKE-PE Study: A Game Changer for Pulmonary Embolism Treatment?
PremiumCompany Announcements
Penumbra Inc.’s STRIKE-PE Study: A Game Changer for Pulmonary Embolism Treatment?
1M ago
PEN
Penumbra Inc.’s STRIDE II Study: A Promising Update for Investors
PremiumCompany Announcements
Penumbra Inc.’s STRIDE II Study: A Promising Update for Investors
1M ago
PEN
Penumbra Inc.’s BOLT Study: A Game-Changer for Deep Vein Thrombosis Treatment?
PremiumCompany AnnouncementsPenumbra Inc.’s BOLT Study: A Game-Changer for Deep Vein Thrombosis Treatment?
1M ago
PEN
Penumbra reports positive results of vacuum thrombectomy in embolism trial
Premium
The Fly
Penumbra reports positive results of vacuum thrombectomy in embolism trial
1M ago
PEN
Penumbra’s Promising Advancements in Medical Technology Justify Buy Rating
Premium
Ratings
Penumbra’s Promising Advancements in Medical Technology Justify Buy Rating
1M ago
PEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >